Core Laboratories (CLB) Lowered to “Hold” at Deutsche Bank

Deutsche Bank cut shares of Core Laboratories (NYSE:CLB) from a buy rating to a hold rating in a report released on Thursday morning. The firm currently has $109.00 price target on the oil and gas company’s stock, down from their prior price target of $116.30.

A number of other brokerages have also recently issued reports on CLB. ABN Amro cut shares of Core Laboratories from a buy rating to a hold rating in a report on Tuesday, January 9th. Royal Bank of Canada set a $110.00 target price on shares of Core Laboratories and gave the company a buy rating in a report on Thursday, December 21st. Zacks Investment Research cut shares of Core Laboratories from a hold rating to a sell rating in a report on Tuesday, November 7th. Loop Capital set a $115.00 target price on shares of Core Laboratories and gave the company a buy rating in a report on Thursday, December 7th. Finally, Cowen set a $100.00 target price on shares of Core Laboratories and gave the company a hold rating in a report on Friday, October 6th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and four have issued a buy rating to the stock. The company has a consensus rating of Hold and an average price target of $110.20.

Core Laboratories (NYSE CLB) traded up $0.11 during trading on Thursday, hitting $119.10. 318,200 shares of the stock were exchanged, compared to its average volume of 433,022. Core Laboratories has a one year low of $86.55 and a one year high of $124.99. The company has a debt-to-equity ratio of 1.53, a quick ratio of 1.81 and a current ratio of 2.18. The firm has a market cap of $5,257.95, a P/E ratio of 68.45 and a beta of 1.56.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings data on Monday, October 23rd. The oil and gas company reported $0.48 EPS for the quarter, topping the Zacks’ consensus estimate of $0.44 by $0.04. Core Laboratories had a net margin of 12.06% and a return on equity of 52.89%. The company had revenue of $166.20 million during the quarter, compared to the consensus estimate of $160.94 million. During the same period in the prior year, the business posted $0.38 EPS. The company’s quarterly revenue was up 1.4% on a year-over-year basis. analysts expect that Core Laboratories will post 1.99 earnings per share for the current year.

A number of institutional investors have recently added to or reduced their stakes in the business. Janus Henderson Group PLC raised its holdings in Core Laboratories by 1.3% in the 2nd quarter. Janus Henderson Group PLC now owns 5,002 shares of the oil and gas company’s stock valued at $506,000 after acquiring an additional 64 shares during the period. ProShare Advisors LLC raised its holdings in Core Laboratories by 2.3% in the 2nd quarter. ProShare Advisors LLC now owns 3,889 shares of the oil and gas company’s stock valued at $394,000 after acquiring an additional 87 shares during the period. Moors & Cabot Inc. raised its holdings in Core Laboratories by 1.1% in the 2nd quarter. Moors & Cabot Inc. now owns 15,902 shares of the oil and gas company’s stock valued at $1,614,000 after acquiring an additional 168 shares during the period. Comerica Securities Inc. raised its holdings in Core Laboratories by 9.1% in the 2nd quarter. Comerica Securities Inc. now owns 2,760 shares of the oil and gas company’s stock valued at $280,000 after acquiring an additional 231 shares during the period. Finally, Advisory Services Network LLC raised its holdings in Core Laboratories by 33.3% in the 2nd quarter. Advisory Services Network LLC now owns 1,365 shares of the oil and gas company’s stock valued at $138,000 after acquiring an additional 341 shares during the period.

WARNING: “Core Laboratories (CLB) Lowered to “Hold” at Deutsche Bank” was published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://stocknewstimes.com/2018/01/15/core-laboratories-clb-lowered-to-hold-at-deutsche-bank.html.

Core Laboratories Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Analyst Recommendations for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply